William Cao

William Cao

Company: Gracell

Job title: CEO


FasT CAR: A Breakthrough Cell Therapy Technology for Malignancies 5:25 pm

Overview of CAR-T industry and discussion of remaining hurdles Gracell’s FasT CAR technology only requires overnight cell manufacturing, setting up new standards Preclinical study verifies Gracell’s FasT CAR-T product characteristics superior to conventional CAR-T Preliminary clinical data demonstrates superior efficacy and safety profileRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.